Tag: Favourable safety profile
AstraZeneca starts Phase 2b clinical study of medicine to lower cholesterol:...
Ionis Pharmaceuticals, Inc. has said that the AstraZeneca has commenced a Phase 2b clinical trial of ION449 (AZD8233).
It is an investigational antisense medicine designed...
